title: What's next after 50 years of psychiatric drug development: an FDA perspective.
authors.affiliation: Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. thomas.laughren@fda.hhs.gov
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Laughren